You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogen receptor positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

Not yet recruiting
  • Low Grade Serous Ovarian Carcinoma
  • Adult Type Granulosa Cell Tumor
  • Gent, Oost-Vlaanderen, Belgium
  • +2 more
May 12, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Metastatic Breast Cancer Trial (Elacestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2022

Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

Not yet recruiting
  • Breast Cancer
  • Beijing, Benjing, China
  • +2 more
Dec 30, 2022

Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 13, 2023

Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)

Completed
  • Advanced ER+, HER2-Negative Breast Cancer
  • Waltham, Massachusetts
    Radius Pharmaceuticals, Inc.
Aug 16, 2022

Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Nov 18, 2022

Breast Cancer Female Trial in Belgium (Palbociclib)

Completed
  • Breast Cancer Female
  • Anderlecht, Belgium
  • +4 more
Jun 23, 2022

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Breast Cancer Trial in New York (core needle biopsy, blood draw)

Recruiting
  • Breast Cancer
  • core needle biopsy
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023

Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • AND019 PO QD
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 19, 2022

Breast Cancer Trial in Philadelphia (BPET/DBT imaging, 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 12, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in Brussels (Prospective data and sample collection,

Not yet recruiting
  • Early-stage Breast Cancer
  • Estrogen-receptor-positive Breast Cancer
  • Prospective data and sample collection
  • +2 more
  • Brussels, Belgium
    Imane Bachir
Nov 27, 2023

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Electronic Medical Record-Based Nudge to Reduce SLNB

Recruiting
  • Breast Cancer
  • Estrogen-receptor-positive Breast Cancer
  • Column-based nudge in the EHR
  • No column-based nudge in the EHR
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Aug 17, 2023